All Registry communications to: Automic Group GPO Box 5193 Sydney NSW 2001 Telephone (free call within Australia): 1300 288 664 ASX Code: TRI Email: [email protected] 27 October 2026 Upcoming Annual General Meeting of Shareholders Dear Shareholder, TrivarX Limited (ACN 008 130 336) (ASX:...
Letter to Shareholders & Notice of AGM & Proxy Form
Filed with ASX · · 38 pages · English
Summary by 6ix AI
Trivarx Limited has issued a letter to shareholders regarding the upcoming Annual General Meeting scheduled for late November. The notice includes details about the meeting agenda, which covers financial statements, resolutions for the adoption of the remuneration report, and the re-election of directors. Shareholders are encouraged to vote on various resolutions, including the approval of an employee incentive plan and the issuance of options to directors. Voting exclusions and proxy voting procedures are also outlined in the document to ensure compliance with regulations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Story so far
Earlier from TrivarX
- Syntro Health Appointed to Support Stabl-Im Clinical Program
- Change of Director's Interest Notice - David Trimboli
- Change of Director's Interest Notice - Chris Ntoumenopoulos
- Notification of cessation of securities - TRI
- Appendix 4G
Later from TrivarX
All TrivarX news releasesFollow TrivarX into a list and get an email when it puts out news.
Follow TrivarX